| Name | Title | Contact Details |
|---|---|---|
Elina Stanford |
VP Information Security | Profile |
DuBois Chemicals, Inc. is a prominent specialty chemical supplier with a history that dates back to 1920. Based in Hamilton, Ohio, the company is dedicated to providing innovative and economical solutions across various industries. DuBois focuses on delivering custom chemical solutions that enhance efficiency and reliability in industrial processes, emphasizing customer satisfaction and sustainability. The company offers a diverse product portfolio that includes cleaning and process solutions for general manufacturing, specialized chemicals for the pulp and paper industry, transportation cleaning solutions, and water treatment chemicals. With a significant facility in Cincinnati, Ohio, DuBois employs over 150 staff members, including scientists and customer service representatives, and has a strong sales team of over 400 representatives serving customers throughout North America. DuBois Chemicals demonstrates financial strength with revenues ranging from $100 million to $1 billion, allowing for continued investment in research and development.
Our main practice areas include Employment Law, Intellectual Property Law, Wills, Trusts & Asset Protection, Business Law, and General Civil Litigation. We have been in business for over twenty years, and our stellar reputation is best reflected in our reviews.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Full Swing is the worldwide leader in cutting-edge indoor golf simulation technology. Full Swing simulators are in the homes of top Tour Pros including Tiger Woods, Jordan Spieth, Jason Day, Jim Furyk, Padraig Harrington, Smylie Kaufman, and many more. Our patented dual tracking technology delivers superior ball tracking data and makes Full Swing the only simulator that actually measures ball flight indoors. With over 30 years of experience, Full Swing provides the most accurate and realistic golf experience you can find. From practice to instruction, to entertainment, this is the world-class experience youve been looking for. For further information, please visit www.fullswinggolf.com.
Nos hemos asociado varias agencias de seguros colombianas con tradición en el mercado y un fondo de inversión americano para formar una red de distribución de seguros en Colombia, con planes de expansión a Centro y Suramérica. Cada agencia mantendrá su independencia bajo la Holding "Grupo ilao", que proporcionará estrategia, software especializado, desarrollo de nuevos productos, reaseguros y conexiones internacionales.